News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,050 Results
Type
Article (42359)
Company Profile (294)
Press Release (673397)
Section
Business (210389)
Career Advice (2091)
Deals (36629)
Drug Delivery (106)
Drug Development (83023)
Employer Resources (175)
FDA (16552)
Job Trends (15396)
News (355938)
Policy (33889)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2591)
Accelerated approval (4)
Adcomms (21)
Allergies (84)
Alliances (51383)
ALS (87)
Alzheimer's disease (1376)
Antibody-drug conjugate (ADC) (117)
Approvals (16553)
Artificial intelligence (249)
Autoimmune disease (18)
Automation (14)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (188)
Bladder cancer (58)
Brain cancer (27)
Breast cancer (253)
Cancer (2049)
Cardiovascular disease (171)
Career advice (1749)
Career pathing (30)
CAR-T (142)
Cell therapy (404)
Cervical cancer (19)
Clinical research (67284)
Collaboration (789)
Compensation (469)
Complete response letters (25)
COVID-19 (2653)
CRISPR (41)
C-suite (217)
Cystic fibrosis (101)
Data (1989)
Decentralized trials (2)
Denatured (26)
Depression (41)
Diabetes (253)
Diagnostics (6421)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (116)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (87910)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114578)
Executive appointments (664)
FDA (17691)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (701)
Gene editing (103)
Generative AI (20)
Gene therapy (294)
GLP-1 (724)
Government (4503)
Grass and pollen (4)
Guidances (49)
Healthcare (18992)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2786)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (89)
Interviews (322)
IPO (16764)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (34)
Layoffs (477)
Leadership (16)
Legal (8371)
Liver cancer (71)
Lung cancer (295)
Lymphoma (136)
Machine learning (4)
Management (59)
Manufacturing (281)
MASH (63)
Medical device (13414)
Medtech (13419)
Mergers & acquisitions (20340)
Metabolic disorders (654)
Multiple sclerosis (72)
NASH (17)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1878)
NextGen: Class of 2025 (6638)
Non-profit (4524)
Northern California (2456)
Now hiring (37)
Obesity (354)
Opinion (226)
Ovarian cancer (73)
Pain (87)
Pancreatic cancer (77)
Parkinson's disease (138)
Partnered (20)
Patents (210)
Patient recruitment (97)
Peanut (49)
People (59079)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20865)
Phase II (29602)
Phase III (22194)
Pipeline (1065)
Podcasts (75)
Policy (125)
Postmarket research (2654)
Preclinical (8842)
Press Release (68)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (376)
Real estate (6252)
Recruiting (67)
Regulatory (23011)
Reports (46)
Research institute (2367)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (72)
Series A (124)
Series B (79)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2125)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3721)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (13)
The Weekly (47)
United States (21521)
Vaccines (677)
Venture capitalists (37)
Webinars (12)
Weight loss (241)
Women's health (33)
Worklife (15)
Date
Today (111)
Last 7 days (738)
Last 30 days (2725)
Last 365 days (34009)
2025 (8365)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56330)
2020 (54792)
2019 (47399)
2018 (35772)
2017 (33142)
2016 (32666)
2015 (38617)
2014 (32517)
2013 (27633)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (49)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40595)
Australia (6503)
California (5600)
Canada (1888)
China (488)
Colorado (250)
Connecticut (257)
Delaware (131)
Europe (86564)
Florida (830)
Georgia (196)
Idaho (57)
Illinois (513)
India (25)
Indiana (300)
Iowa (9)
Japan (146)
Kansas (100)
Kentucky (23)
Louisiana (8)
Maine (61)
Maryland (841)
Massachusetts (4254)
Michigan (211)
Minnesota (372)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1606)
New Mexico (29)
New York (1609)
North Carolina (942)
North Dakota (7)
Northern California (2456)
Ohio (192)
Oklahoma (14)
Oregon (38)
Pennsylvania (1270)
Puerto Rico (9)
Rhode Island (27)
South America (1160)
South Carolina (18)
South Dakota (1)
Southern California (2125)
Tennessee (94)
Texas (841)
Utah (166)
Virginia (138)
Washington D.C. (57)
Washington State (522)
West Virginia (3)
Wisconsin (51)
716,050 Results for "lotus pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
NRx Pharmaceuticals, Inc. today announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRx clinical trial in bipolar depression as a material event in is February 7 financial filing.
February 9, 2024
·
3 min read
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced the advance of the first $5 million milestone payment based on the Company’s partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW).
February 12, 2024
·
3 min read
Business
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
Lotus Pharmaceuticals (1795:TT; “Lotus”) and NRx Pharmaceuticals Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals or NRx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets.
June 5, 2023
·
11 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Press Releases
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 8, 2024
·
5 min read
Press Releases
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
March 25, 2025
·
4 min read
Biotech Beach
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be presented at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting, being held this week in Westminster, Colorado.
June 18, 2024
·
10 min read
Business
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
Amarin Corporation plc and Lotus Pharmaceuticals announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® across 10 countries, including nine in Southeast Asia and South Korea.
July 31, 2023
·
7 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
April 3, 2025
·
5 min read
Press Releases
Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
March 10, 2025
·
6 min read
1 of 71,605
Next
